• Home
  • Research
  • Publications
  • More
    • Team
    • Contact
    • News
    • TATAMI project
    • PROMETEO Project
    • SMA Projects
    • DONAR / DONATE
    • Spin-off companies
  • Home
  • Research
  • Publications
  • More
    • Team
    • Contact
    • News
    • TATAMI project
    • PROMETEO Project
    • SMA Projects
    • DONAR / DONATE
    • Spin-off companies
ARTERO'S LAB
  • Home
  • Research
  • Publications
  • More
    • Team
    • Contact
    • News
    • TATAMI project
    • PROMETEO Project
    • SMA Projects
    • DONAR / DONATE
    • Spin-off companies
Picture
Picture
Myotonic Dystrophy

News

News about Translational Genomics Group conferences, awards, advances in therapies and related activities​.
Spinal Muscular Atrophy

Research

Research on Myotonic Dystrophy (DM),  Spinal Muscular Atrophy (SMA) and Limb-Girdle Muscular Dystrophy type 1F/D2 (LGMD1F/D2)
Limb-Girdle Muscular Dystrophy type 1F

Publications

Selection of articles published during the last 5 years in different journals of international prestige.

What we research​

mechanisms of pathogenesis
Our overall objective is to understand mechanisms of pathogenesis, and to discover therapeutic targets and innovative treatments for human genetic diseases. We make use of human specimens and animal models to understand the molecular basis of a disease, perform drug screening and evaluate the activity of candidate drugs.
​
Our drug screening platforms offer a rapid, effective, and economical system to validate chemical compounds for their utility as drugs in the studied pathological conditions.

Our long term aspiration is the application of our research findings and the transformation of biomedical knowledge into products or services for the society. For that purpose, we are pursuing collaboration with spin-offs and start-ups.
Tweets by GenomicsLab_UV

Tweets by RubenArtero3

treatments for human genetic diseases

DONATE (help us) on our research in:
DM1
LGMD-1F
Incliva
Universidad de Valencia
Translational Genomics Group